These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1653245

  • 1. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase.
    Tarbet EB, Stafforini DM, Elstad MR, Zimmerman GA, McIntyre TM, Prescott SM.
    J Biol Chem; 1991 Sep 05; 266(25):16667-73. PubMed ID: 1653245
    [Abstract] [Full Text] [Related]

  • 2. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
    Stafforini DM, McIntyre TM, Carter ME, Prescott SM.
    J Biol Chem; 1987 Mar 25; 262(9):4215-22. PubMed ID: 3549727
    [Abstract] [Full Text] [Related]

  • 3. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
    Stafforini DM, Carter ME, Zimmerman GA, McIntyre TM, Prescott SM.
    Proc Natl Acad Sci U S A; 1989 Apr 25; 86(7):2393-7. PubMed ID: 2928339
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E.
    Biochem J; 2001 Jul 15; 357(Pt 2):457-64. PubMed ID: 11439095
    [Abstract] [Full Text] [Related]

  • 9. Release of platelet-activating factor in systemic lupus erythematosus.
    Tetta C, Bussolino F, Modena V, Montrucchio G, Segoloni G, Pescarmona G, Camussi G.
    Int Arch Allergy Appl Immunol; 1990 Jul 15; 91(3):244-56. PubMed ID: 2354868
    [Abstract] [Full Text] [Related]

  • 10. PAF-acetylhydrolase, predominantly present in LDL in healthy subjects, is associated with HDL in a patient with LDL deficiency.
    Surya II, Mommersteeg M, Erkelens DW, Akkerman JW.
    J Lipid Mediat; 1991 Jul 15; 3(1):27-38. PubMed ID: 1768838
    [Abstract] [Full Text] [Related]

  • 11. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
    Stafforini DM, Tjoelker LW, McCormick SP, Vaitkus D, McIntyre TM, Gray PW, Young SG, Prescott SM.
    J Biol Chem; 1999 Mar 12; 274(11):7018-24. PubMed ID: 10066756
    [Abstract] [Full Text] [Related]

  • 12. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).
    Pritchard PH, Chonn A, Yeung CC.
    Blood; 1985 Dec 12; 66(6):1476-8. PubMed ID: 4063532
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver.
    Howard KM, Miller JE, Miwa M, Olson MS.
    J Biol Chem; 1997 Oct 31; 272(44):27543-8. PubMed ID: 9346888
    [Abstract] [Full Text] [Related]

  • 15. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
    Dentan C, Lesnik P, Chapman MJ, Ninio E.
    Arterioscler Thromb; 1994 Mar 31; 14(3):353-60. PubMed ID: 8123638
    [Abstract] [Full Text] [Related]

  • 16. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.
    Miwa M, Miyake T, Yamanaka T, Sugatani J, Suzuki Y, Sakata S, Araki Y, Matsumoto M.
    J Clin Invest; 1988 Dec 31; 82(6):1983-91. PubMed ID: 3198761
    [Abstract] [Full Text] [Related]

  • 17. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR, La Belle M, Forte TM, Krauss RM, Takanami Y, Tribble DL.
    Biochim Biophys Acta; 1999 Jan 29; 1437(1):23-36. PubMed ID: 9931415
    [Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.
    Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Hiramoto M, Takamatsu S, Takamatsu M.
    J Clin Invest; 1991 Feb 29; 87(2):476-81. PubMed ID: 1846878
    [Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
    Min JH, Wilder C, Aoki J, Arai H, Inoue K, Paul L, Gelb MH.
    Biochemistry; 2001 Apr 17; 40(15):4539-49. PubMed ID: 11294621
    [Abstract] [Full Text] [Related]

  • 20. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
    Tselepis AD, Dentan C, Karabina SA, Chapman MJ, Ninio E.
    Arterioscler Thromb Vasc Biol; 1995 Oct 17; 15(10):1764-73. PubMed ID: 7583554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.